https://www.selleckchem.com/products/SB939.html
Prolonged delays in cancer screening will increase cancer in the overall population from pre-COVID-19 trajectories, and elevate the cancer disparity in minority populations. Knowing the overall benefit of cancer screening versus the risk of acquiring COVID-19, utilizing at-home screening tests and keeping the COVID-19-induced delay in screening to a minimum might slow the growth of disparity. To report the improvements achieved with clinical decision support systems and examine the heterogeneity from pooling effects across diverse clinica
Like
Comment
Share
